Follow The Filings

Humacyte position history

The shares of Humacyte that DAVIDSON KEMPNER CAPITAL MANAGEMENT LP reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q2: 900,000 shares, $2.6M, 0.07% of portfolio, New
  2. 2023 Q3: not held, Exit
  3. 2023 Q4: not held
  4. 2024 Q1: not held
  5. 2024 Q2: not held
  6. 2024 Q3: not held
  7. 2024 Q4: not held
  8. 2025 Q1: not held
  9. 2025 Q2: not held
  10. 2025 Q3: not held
  11. 2025 Q4: not held
  12. 2026 Q1: not held
  13. 2026 Q2: 5,000,000 shares, $3.9M, 0.05% of portfolio, New
Holdings date Value % of holdings Shares Filing date All 13F holders